Pharmafile Logo
Pharmafocus logo
Advanced Search

generics

Showing 15 posts of 209 posts found.

fda2outsideweb

FDA approved more generics in July than any previous month

August 10, 2018
Medical Communications FDA, generics, pharma

FDA Commissioner Scott Gottlieb took to Twitter to announce the news that the FDA smashed its previous record for number …

News
16193381408_003eb2fdc9_z1

Irish trade lobby warns EU amendments could threaten pharma industry in Ireland, critics contest

August 6, 2018
Sales and Marketing EU, IPHA, Ireland, biosimilars, generics, intellectual property, trade lobby

The Irish Pharmaceutical Healthcare Association (IPHA) has warned that changes to existing intellectual property legislation could threaten innovation and deter …

News
rowa_vmax

Biosimilars and generics saved NHS £324m last year

August 2, 2018
Medical Communications, Sales and Marketing Cancer, NHS, biosimilars, funding, generics

The NHS watchdog, NHS Improvement, has revealed that the British National Health Service saved £324 million last financial year by …

News
roche_dark_0

Roche join Pfizer and others in price freeze while critics pose questions

July 23, 2018
Sales and Marketing Donald Trump, Roche, generics, price freezes

Swiss multinational Roche has joined Pfizer and others in halting price hikes. However critics have condemned the move as observers …

News

Cadila scores FDA approval for BMS and Alvogen generics

July 3, 2018
Manufacturing and Production, Sales and Marketing Adolat, Alvogen, Bristol-Myers Squibb, Cadila, FDA, Questran, generics, pharma

Cadila Healthcare has announced that it has gained FDA final approval to market nifedipine ER tablets in the strengths of …

News
japan-112722_640

Japan saves record $12.2bn in 2017 through greater generic use

March 7, 2018
Research and Development, Sales and Marketing Japan, generics, keytruda, opdivo, pharma

Through a concerted shift from branded drugs to generic equivalents as a means to lower prescription costs, Japan is estimated …

News

Novartis sheds generics plant and 450 jobs amid pricing pressure

October 18, 2017
Manufacturing and Production, Research and Development Novartis, US, closure, generics, manufacturing, pharma

Novartis has announced its intention to shut down its US generics manufacturing plant in Broomfield, Colorado, a move that will …

News

FDA to expedite complex generic approvals to lower drug prices through competition

October 3, 2017
Manufacturing and Production, Sales and Marketing Donald Trump, Drug pricing, FDA, generics, pharma, pharmaceutical

In the midst of ongoing discussions over drug pricing, the FDA has announced plans to facilitate accelerated access to generic …

News
cost_coins

Hikma risks a stratospheric 430% price increase on product

August 22, 2017
Manufacturing and Production, Sales and Marketing Hikma, biotech, drugs, generics, pharma, pharmaceutical

It wasn’t so long ago that pharmaceutical companies could change the prices of its products with little scrutiny. A series …

News
pills_in_hand

The pendulum swing of generic drug prices

August 18, 2017
Medical Communications biotech, drugs, generics, pharma, pharmaceutical

The prices of generic drugs have been driven lower as companies compete to undercut one another. This has led to …

News
headquarters_2013_endo

Endo pulls plug on Alabama plant, 875 jobs lost

July 25, 2017
Manufacturing and Production Endo, Qualitest, biotech, drugs, generics, pharma, pharmaceutical

Endo International has announced that it will close down its manufacturing and distribution facilities in Huntsville, Alabama, as part of …

News
teva_copy

Teva to cut over 300 production jobs in Israel

July 24, 2017
Manufacturing and Production, Sales and Marketing Teva, biotech, drugs, generics, healthcare, pharma, pharmaceutical

Teva, one of the world’s biggest generics firms and the biggest company in Israel, has revealed it plans to slash …

News
teva_copy

Teva accuses ex-employee of passing company secrets to boyfriend at rival generics firm

July 12, 2017
Research and Development, Sales and Marketing Apotex, Teva, biotech, drugs, generics, healthcare, pharma, pharmaceuticals

Of all the controversy Teva has been embroiled in over the past years, the Israeli company now finds itself dogged …

News

Stada takeover back in motion after revised bid

July 12, 2017
Research and Development Bain capital, Cinven, Stada, biotech, drugs, generics, pharma, pharmaceutical

Stada, the German generic manufacturer, has had a particularly protracted takeover journey to reach a point, now, where it looks …

News

73% of India’s doctors oppose prescribing generics over branded versions

May 9, 2017
Manufacturing and Production, Sales and Marketing India, generics

Following a recent push by Indian Prime Minister Narendra Modi for doctors in the country to prescribe generic drugs over …

News

Latest content

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023

FDA grants breakthrough device designation to Inflammatix’s TriVerity Acute Infection and Sepsis Test System

November 29, 2023

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023